Myriad Sues Third Firm, BioReference's GeneDx, Alleging BRCA1/2 Patent Infringement | GenomeWeb

NEW YORK (GenomeWeb News) – Myriad Genetics and other parties are suing BioReference Laboratories' GeneDx alleging infringement of patents covering BRCA1 and BRCA2 genes.

Along with Myriad, the University of Utah Research Foundation, the trustees of the University of Pennsylvania, Toronto's Hospital for Sick Children, and Endorecherche are plaintiffs in the lawsuit, which was filed last week in US District Court for the District of Utah, Central Division.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: statistical approach to examine intra-tumor heterogeneity, new genetic condition called otulipenia, and more.

Blood tests looking for biomarker changes could catch mental illnesses earlier, Newsweek reports.

DNA testing offers Korean adoptees a way to find their birth parents that sidesteps bureaucratic red tape, according to the New York Times.

A National Institutes of Health researcher has filed an Equal Employment Opportunity complaint against the agency, the Washington Post reports.